Five Items on Pertussis in Developing Countries

Wednesday, 16th of November 2016

Five Items on Pertussis in Developing Countries

Among the vaccine preventable diseases, pertussis is perhaps among those least studied in the developing world. Here are five recent contributions to the pertussis literature. Some authors propose the introduction of TDaP for maternal vaccination; this product is not commonly used in the developing world, where whole cell vaccines are still preferred.

The last item calls for a systematic review of the literature on pertussis burden; no such review has appeared in the year since the item’s publication.

Good reading.

Assessing the Evidence for Maternal Pertussis Immunization: A Report from the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106619/

What Pertussis Mortality Rates Make Maternal Acellular Pertussis Immunization Cost-Effective in Low- and Middle-Income Countries? A Decision Analysis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106625/

Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil

https://www.ncbi.nlm.nih.gov/pubmed/26899375

Epidemiology of Pertussis among Young Pakistani Infants: A Community-Based Prospective Surveillance Study

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106628/

The burden of pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunization (EPI) in 1974: a systematic review protocol.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419482/